View by sections
GLO J71: Treating Drug Dependence and its Health Consequences- TREATNET Phase II
|No. and Title:||GLO J71: Treating Drug Dependence and its Health Consequences- TREATNET Phase II|
|Status/Starting Date:||January 2008|
|Project Function:||Drug Demand Reduction|
|Executing Agency:||UNODC, Health and Human Development Section (Prevention, Treatment and Rehabilitation Unit)|
This global project builds upon its predecessor, TREATNET Phase I, implemented in response to UNODC's mandate to support the provision of quality drug treatment services among the member states. For two years in TREATNET Phase I, a global network of 20 resource centres worked collaboratively to improve the quality of treatment, developed a comprehensive training package on evidence based treatment methods; trained 26 trainers from within the network centres who in turn have trained more than 500 service providers; and developed good practice documents on four key topics. TREATNET Phase II expands on these previous works and findings through three lines of action:
• advocacy for the dissemination of the understanding of drug dependence as a health disorder and the need to approach it from a health perspective;
• capacity building of trainers and practitioners of drug dependence treatment; and
• demonstration and expansion of evidence and community -based drug dependence treatment services.
The ultimate goal is to increase access to drug treatment for all those in need thus reducing the negative health and social consequences of drug dependence, including HIV and AIDS. GloJ71 (Treatnet II) is implemented in five regions, including South East Asia.
For further information please visit http://www.unodc.org/treatnet
National sustained commitment to increased access to quality and affordable drug dependence treatment services thus contributing to reduce negative health and social consequences of drug use including HIV.
This project will contribute to achieving that all persons whose lives are impaired by drug use receive a wide range of quality services, therefore reducing their drug use and its related health and social consequences. It is also expected that the project interventions will improve the well-being and social integration of the beneficiaries, who will then become active and productive members of their societies.
In the countries where the project will be implemented:
Enhanced capacity for increased access to quality, affordable drug dependence treatment services
Output 1: A partnership under the leadership of UNODC and WHO developed a strategy to advocate for quality drug dependence treatment and gain donors support for field-based drug treatment projects implemented.
Output 2: Report on the state of drug use and dependence, associated HIV, drug dependence treatment services and training needs in each targeted country. The report includes identified needs and priorities.
Output 3: National coordination and exchange mechanisms are established to promote commitment to HIV prevention, in particular through the improvement of drug dependence treatment services, among Governments and relevant agencies.
Output 4: National mechanism for coordination of training established, training materials on comprehensive evidence-based approaches available and training of service providers and other relevant professionals delivered.
Output 5: Service provision networks established with the objective of delivering low cost and decentralized HIV prevention and drug dependence treatment services linking to the primary health care system.
Output 6: Participating service providing networks have a set of agreed quality standards for service provision.
Output 7 Regional coordination and exchange mechanisms are established to share experiences and good practices and jointly adapt project tools to regional circumstances.
Output 8: Strategy implemented to gain external partners support to expand quality HIV prevention and care through drug dependence treatment.
Output 9: Best practice tools on HIV prevention and care through drug dependence treatment are developed/ adapted and disseminated.
Output 10: Policy-related technical reports produced and technical assistance provided to UNODC and Member States as required.
Output 11: Project activities are monitored and evaluated.
• Project execution: UNODC will be the main executing agency.
• UNODC is well placed to meet the needs of the participating countries in this area, given the availability of in house expertise in drug dependence treatment and rehabilitation.
• The project works under the umbrella of the broader UNODC-WHO Joint Programme on Drug Dependence Treatment
• The implementation of the project is supported by a Project Coordination Unit (Core Team) based in Vienna working under the supervision of the Chief of the Health and Human Development Section. The Project Coordination Unit maintains the overarching responsibility on behalf of UNODC for project implementation and provides the necessary technical assistance and support to the Regional Coordinators in the target regions.
• In relation to the participating countries, UNODC work through its Field and Regional Offices to provide the required assistance. Regional Coordinators are placed in key countries in the regions to coordinate the provision of the required technical assistance. The Regional Coordinators are responsible for the implementation, coordination and liaison of the project at regional and national level and provide operational management of the project according to the project document, including day-to-day business.
• UNODC Field Offices in the region are consulted and provide their assistance to facilitate monitoring and implementation of activities. UNODC field offices facilitate synergies with other ongoing and planned drug dependence treatment. initiatives
• To ensure broad ownership and a timely implementation of project activities, National Coordination Groups and/or Task Forces, chaired by a Focal Point, are set up in participating countries. The National Coordination Group consists of relevant Government counterparts including representatives from the Ministry of Health and other relevant ministries, academic institutions, and representatives of drug dependence treatment centres (private non-for-profit and public). The National Coordination Groups are responsible for implementation of the national activities under the project in close cooperation with the UNODC Regional Coordinator.
• Individual Letter of Agreements will be signed with each Government counterparts for the implementation of project activities.
• The project will develop a system that will collect data and information analysis for monitoring and evaluation purposes. An independent evaluation will be carried-out at the mid-term and the end of the project.